drugset
drugset / Press release

The Lancet Publishes Data from Protégé, MacroGenics' Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients

2011-06-28 · MacroGenics · original macrogenics.com ↗

Teplizumab

The Lancet Publishes Data from Protégé, MacroGenics’ Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients 16.6 KB

The release as fetched from its publisher. macrogenics.com ↗